| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $263.4M | +235.5% |
| R&D Expense | $348.2M | -8.3% |
| SG&A Expense | $165.4M | +64.9% |
| Operating Income | -$250.2M | +37.7% |
| Interest Expense | $0 | — |
| Pre-tax Income | -$198.3M | +45.5% |
| Income Tax | $600K | -33.3% |
| Net Income | -$198.9M | +45.8% |
| EPS (Basic) | -$2.77 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $100.5M | -67.8% |
| Short-term Investments | $938.9M | -1.1% |
| Accounts Receivable | $5.7M | — |
| Current Assets | $1.07B | -16.6% |
| Total Assets | $1.09B | -16.3% |
| Current Liabilities | $229.8M | -10.6% |
| Long-term Debt | $800K | -20.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$259.3M | +25.4% |
| Capital Expenditures | $1.8M | -37.9% |
| Investing Cash Flow | $34.7M | -82.9% |
| Financing Cash Flow | $7.9M | -97.9% |
| Free Cash Flow | -$261.1M | +25.5% |
| +58.2% |
| EPS (Diluted) | -$2.77 | +58.2% |
| Total Liabilities |
| $529.7M |
| -17.8% |
| Stockholders' Equity | $561.7M | -14.9% |